INOVIS  INSIGHTS

Are you Planning for Survival?

NB : INOVIS Tech is the boutique branch of the global INOVIS group that specializes in creative, tailored, proactive CI services for a select number of InfoTech & MedTech clients. By comparison, INOVIS Life Sciences, which focusses on Pharma & Biotech, is a mid-sized agency offering both bespoke CI solutions and proprietary in-house CI tools to a broader client base in the Life Sciences field. Both the Pharma and Tech sides' strict specialty and focus create synergies from each entity's talent pool and experience.

READ MORE INSIGHTS FROM THE INOVIS TECH GROUP

Resilience Planning is essentially an internal risk-management discipline.  It's about survival and continuity and typically involves:

• Ensuring organizational continuity under stress
• Preparing for disruptions (supply chain, economic shocks, regulatory shifts, natural disasters)
• Building adaptive capacity and redundancy into ongoing operations
• Protecting core operations and stakeholder commitments

Competitive Intelligence (CI), on the other hand, is an externally-oriented analytical discipline.  It's about gaining a competitive advantage through:

• Systematically gathering and analyzing competitor data
• Understanding market positioning and rivals' strategies
• Informing strategic decision-making through environmental scanning

The two are very different practices, but they are also complementary.

So, how can CI activities enrich Resilience Planning?

While most Resilience Planning is inward-facing, Competitive Intelligence can inform and enrich the process through :

Scenario Development & Stress Testing
CI provides real-world data to make scenarios more realistic and grounded

Early Warning Systems
CI acts as an environmental radar that scans competitor activity, human intel networks, technological advancements, regulatory shifts, and more

Benchmarking Resilience Capabilities
CI helps organizations understand where your company stands relative to competitors, e.g., supply chain diversification, financial reserves, and operational redundancy

Talent & Knowledge Resilience
CI on competitor workforce strategies, talent pipelines, and restructuring can signal a broader industry stress

Innovation & Adaptive Strategy
CI on competitors' R&D investments and pivots during disruptions can uncover unique adaptive strategies worth considering

Ethical and Strategic Considerations

The key is viewing this as "competing through resilience" rather than "profiting from disasters." This subtle but important distinction guides organizations toward sustainable competitive advantages while maintaining ethical business practices and long-term market relationships. The most successful organizations use this intelligence to build genuine competitive advantages through superior resilience, rather than simply waiting to exploit others' misfortunes.

[ LEGAL & ETHICAL GUARDRAILS FOR CI ]

Bottom line

Resilience Planning transforms risk management into a competitive advantage by allowing firms to "see around corners" and manoeuvre proactively. Incorporating Competitive Intelligence research and analysis directly into your resilience playbooks, scenario libraries, and crisis decision trees is essential so that when disruption hits, your organization isn't just surviving, it's adapting faster than competitors.

For over three decades, INOVIS has been actively listening — genuinely curious about others' thoughts and providing nuanced information that can only be gathered through primary intelligence. We help client teams collectively reach constructive and actionable outcomes in their strategic planning.

Interested in our process? Let's Chat!

Since 1992, INOVIS has supported decision-making, implementation and execution across the LIFE SCIENCES and TECHNOLOGIES sectors, leveraging world-class CI and marketing expertise through a network of experienced senior industry leaders who advance strategic thinking and nurture company and brand strategies.

If you think our specialized services might be a great match for your competitive strategy development,

OR, if you are interested in working with a tight-knit, dynamic team [ more info ] ,

Marc Limacher
INOVIS Founder & CEO INOVIS Inc.
CI for Technologies [infotech, fintech,  medtech]
Board Member for INOVIS AG
      

A 30+year veteran in the CI and counter-intelligence industry, Marc Limacher has grown INOVIS into a global leader in primary intelligence and strategic consulting services, serving a select group of global Fortune 100 companies as loyal clients. He is responsible for the overall strategic direction of the firm and manages the operation of the Technologies practice.

Prior to INOVIS, Marc was Director of Market Intelligence at a leading U.S. institutional investment firm for five years, providing primary intelligence on small-/medium-/large-cap life science equities via a global employee network of 125 investigative journalists. He also delivers private CI seminars and is a frequent lecturer on CI and counter-intelligence topics at companies and to academia.